Targeting postprandial hyperglycaemia in patients with type 2 diabetes: Nateglinide vs acarbose

被引：0
|
作者：
Holmes, D
Raccah, D
Escobar-Jimenez, F
Standl, E
机构：
[1] Novartis Pharma, Basel, Switzerland
[2] Novartis Pharma, Marseille, France
[3] Novartis Pharma, Granada, Spain
[4] Novartis Pharma, Munich, Germany
来源：
DIABETOLOGIA | 2001年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
825
引用
收藏
页码：A215 / A215
页数：1
相关论文
共 50 条
  • [21] Effect of acarbose on postprandial lipid metabolism in type 2 diabetes mellitus
    Kado, S
    Murakami, T
    Aoki, A
    Nagase, T
    Katsura, Y
    Noritake, M
    Matsuoka, T
    Nagata, N
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 41 (01) : 49 - 55
  • [22] Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart
    Gredal, Charlotte
    Rosenfalck, Anne Mette
    Dejgaard, Anders
    Hilsted, Jannik
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2008, 68 (08): : 739 - 744
  • [23] Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients
    Matsumura, Mihoko
    Monden, Tsuyoshi
    Miyashita, Yasushi
    Kawagoe, Yoshiaki
    Shimizu, Hiroaki
    Nakatani, Yuki
    Domeki, Nozomi
    Yanagi, Kazunori
    Ikeda, Shiori
    Kasai, Kikuo
    ADVANCES IN THERAPY, 2009, 26 (06) : 660 - 666
  • [24] Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients
    Mihoko Matsumura
    Tsuyoshi Monden
    Yasushi Miyashita
    Yoshiaki Kawagoe
    Hiroaki Shimizu
    Yuki Nakatani
    Nozomi Domeki
    Kazunori Yanagi
    Shiori Ikeda
    Kikuo Kasai
    Advances in Therapy, 2009, 26 : 660 - 666
  • [25] Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes
    Vakkilainen, J
    Mero, N
    Schweizer, A
    Foley, JE
    Taskinen, MR
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (06) : 484 - 490
  • [26] Nateglinide reduces postprandial glucose levels, with a low risk of hypoglycaemia in patients with type 2 diabetes mellitus
    Drugs & Therapy Perspectives, 2003, 19 (5) : 1 - 4
  • [27] The effect of nateglinide on postprandial hyperglycemia and oxidative stress in Type 2 diabetes mellitus
    Yoo, Jeong Seon
    Nam, Ji Sun
    Jung, Han Young
    Han, Jung Woo
    Cho, Min Ho
    Park, Jong Suk
    Ahn, Chul Woo
    Cha, Bong Soo
    Kim, Kyung Rae
    Lee, Hyun Chul
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S73 - S73
  • [28] Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus
    Pattanaik, S. R.
    Shah, Parag
    Baker, Abu
    Sinha, Navin
    Kumar, Neeraj
    Swami, Onkar C.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2018, 12 (04) : OE8 - OE12
  • [29] Defining the Role of Insulin Lispro in the Management of Postprandial Hyperglycaemia in Patients with Type 2 Diabetes Mellitus
    D. Giugliano
    A. Ceriello
    E. Razzoli
    K. Esposito
    Clinical Drug Investigation, 2008, 28 : 199 - 210
  • [30] Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus
    Giugliano, D.
    Ceriello, A.
    Razzoli, E.
    Esposito, K.
    CLINICAL DRUG INVESTIGATION, 2008, 28 (04) : 199 - 210
12345